OBJECTIVE: The aim of this study was to investigate how head and neck squamous cell carcinoma (HNSCC) tissue biopsies maintained in a pseudo in vivo environment within a bespoke microfluidic device respond to radiation treatment. STUDY DESIGN: Feasibility study. SETTING: Tertiary referral center. SUBJECTS AND METHODS: Thirty-five patients with HNSCC were recruited, and liver tissue from 5 Wistar rats was obtained. A microfluidic device was used to maintain the tissue biopsy samples in a viable state. Rat liver was used to optimize the methodology. HNSCC was obtained from patients with T1-T3 laryngeal or oropharyngeal SCC; N1-N2 metastatic cervical lymph nodes were also obtained. Irradiation consisted of single doses of between 2 Gy and 40 Gy and a fractionated course of 5×2 Gy. Cell death was assessed in the tissue effluent using the soluble markers lactate dehydrogenase (LDH) and cytochrome c and in the tissue by immunohistochemical detection of cleaved cytokeratin18 (M30 antibody). RESULTS: A significant surge in LDH release was demonstrated in the rat liver after a single dose of 20 Gy; in HNSCC, it was seen after 40 Gy compared with the control. There was no significant difference in cytochrome c release after 5 Gy or 10 Gy. M30 demonstrated a dose-dependent increase in apoptotic index for a given increase in single-dose radiotherapy. There was a significant increase in apoptotic index between 1×2 Gy and 5×2 Gy. CONCLUSION: M30 is a superior method compared with soluble markers in detecting low-dose radiation-induced cell death. This microfluidic technique can be used to assess radiation-induced cell death in HNSCC and therefore has the potential to be used to predict radiation response.
OBJECTIVE: The aim of this study was to investigate how head and neck squamous cell carcinoma (HNSCC) tissue biopsies maintained in a pseudo in vivo environment within a bespoke microfluidic device respond to radiation treatment. STUDY DESIGN: Feasibility study. SETTING: Tertiary referral center. SUBJECTS AND METHODS: Thirty-five patients with HNSCC were recruited, and liver tissue from 5 Wistar rats was obtained. A microfluidic device was used to maintain the tissue biopsy samples in a viable state. Rat liver was used to optimize the methodology. HNSCC was obtained from patients with T1-T3 laryngeal or oropharyngeal SCC; N1-N2 metastatic cervical lymph nodes were also obtained. Irradiation consisted of single doses of between 2 Gy and 40 Gy and a fractionated course of 5×2 Gy. Cell death was assessed in the tissue effluent using the soluble markers lactate dehydrogenase (LDH) and cytochrome c and in the tissue by immunohistochemical detection of cleaved cytokeratin18 (M30 antibody). RESULTS: A significant surge in LDH release was demonstrated in the rat liver after a single dose of 20 Gy; in HNSCC, it was seen after 40 Gy compared with the control. There was no significant difference in cytochrome c release after 5 Gy or 10 Gy. M30 demonstrated a dose-dependent increase in apoptotic index for a given increase in single-dose radiotherapy. There was a significant increase in apoptotic index between 1×2 Gy and 5×2 Gy. CONCLUSION: M30 is a superior method compared with soluble markers in detecting low-dose radiation-induced cell death. This microfluidic technique can be used to assess radiation-induced cell death in HNSCC and therefore has the potential to be used to predict radiation response.
Entities:
Keywords:
head and neck squamous cell carcinoma; microfluidic techniques; radiotherapy; rat liver
Authors: Mohammad M N Esfahani; Mark D Tarn; Tahmina A Choudhury; Laura C Hewitt; Ashley J Mayo; Theodore A Rubin; Mathew R Waller; Martin G Christensen; Amy Dawson; Nicole Pamme Journal: Biomicrofluidics Date: 2016-02-02 Impact factor: 2.800
Authors: R Kennedy; D Kuvshinov; A Sdrolia; E Kuvshinova; K Hilton; S Crank; A W Beavis; V Green; J Greenman Journal: Sci Rep Date: 2019-04-19 Impact factor: 4.379
Authors: Amy J C Dohmen; Justin E Swartz; Michiel W M Van Den Brekel; Stefan M Willems; René Spijker; Jacques Neefjes; Charlotte L Zuur Journal: Cancers (Basel) Date: 2015-08-28 Impact factor: 6.639
Authors: Ruth Bower; Victoria L Green; Elena Kuvshinova; Dmitriy Kuvshinov; Laszlo Karsai; Stephen T Crank; Nicholas D Stafford; John Greenman Journal: Future Sci OA Date: 2017-03-07